NFLX Long 4:1 R:R
NFLX is at support, which has held a few times already.
Although the recent news about Pfizer's vaccine had a negative impact, the company did benefit from subscriber growth during the pandemic and is in overall a good spot.
I see this trade as worth taking, considering the R:R ratio but will nevertheless be cautious, as tech might continue to trend down heavily duo to the vaccine news.
Although the recent news about Pfizer's vaccine had a negative impact, the company did benefit from subscriber growth during the pandemic and is in overall a good spot.
I see this trade as worth taking, considering the R:R ratio but will nevertheless be cautious, as tech might continue to trend down heavily duo to the vaccine news.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.